Charles River Laboratories International (CRL) Income from Continuing Operations (2016 - 2025)
Historic Income from Continuing Operations for Charles River Laboratories International (CRL) over the last 17 years, with Q3 2025 value amounting to $55.6 million.
- Charles River Laboratories International's Income from Continuing Operations fell 2096.74% to $55.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$79.6 million, marking a year-over-year decrease of 11860.32%. This contributed to the annual value of $25.3 million for FY2024, which is 9473.51% down from last year.
- Per Charles River Laboratories International's latest filing, its Income from Continuing Operations stood at $55.6 million for Q3 2025, which was down 2096.74% from $52.7 million recorded in Q2 2025.
- Over the past 5 years, Charles River Laboratories International's Income from Continuing Operations peaked at $189.1 million during Q4 2022, and registered a low of -$213.7 million during Q4 2024.
- Its 5-year average for Income from Continuing Operations is $80.6 million, with a median of $94.3 million in 2024.
- As far as peak fluctuations go, Charles River Laboratories International's Income from Continuing Operations soared by 4894.19% in 2022, and later crashed by 21312.24% in 2024.
- Quarter analysis of 5 years shows Charles River Laboratories International's Income from Continuing Operations stood at $139.8 million in 2021, then surged by 35.24% to $189.1 million in 2022, then dropped by 0.08% to $189.0 million in 2023, then crashed by 213.12% to -$213.7 million in 2024, then skyrocketed by 125.99% to $55.6 million in 2025.
- Its Income from Continuing Operations was $55.6 million in Q3 2025, compared to $52.7 million in Q2 2025 and $25.9 million in Q1 2025.